Cargando…
Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495272/ https://www.ncbi.nlm.nih.gov/pubmed/32939841 http://dx.doi.org/10.1111/bcp.14511 |
| _version_ | 1783582905313787904 |
|---|---|
| author | Stegemann, Sven van Riet‐Nales, Diana de Boer, Anthonius |
| author_facet | Stegemann, Sven van Riet‐Nales, Diana de Boer, Anthonius |
| author_sort | Stegemann, Sven |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7495272 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74952722020-09-24 Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life Stegemann, Sven van Riet‐Nales, Diana de Boer, Anthonius Br J Clin Pharmacol Editorial‐themed Section John Wiley and Sons Inc. 2020-09-17 2020-10 /pmc/articles/PMC7495272/ /pubmed/32939841 http://dx.doi.org/10.1111/bcp.14511 Text en © 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Editorial‐themed Section Stegemann, Sven van Riet‐Nales, Diana de Boer, Anthonius Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| title | Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| title_full | Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| title_fullStr | Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| title_full_unstemmed | Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| title_short | Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| title_sort | demographics in the 2020s—longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life |
| topic | Editorial‐themed Section |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495272/ https://www.ncbi.nlm.nih.gov/pubmed/32939841 http://dx.doi.org/10.1111/bcp.14511 |
| work_keys_str_mv | AT stegemannsven demographicsinthe2020slongevityasachallengeforpharmaceuticaldrugdevelopmentprescribingdispensingpatientcareandqualityoflife AT vanrietnalesdiana demographicsinthe2020slongevityasachallengeforpharmaceuticaldrugdevelopmentprescribingdispensingpatientcareandqualityoflife AT deboeranthonius demographicsinthe2020slongevityasachallengeforpharmaceuticaldrugdevelopmentprescribingdispensingpatientcareandqualityoflife |